Determination of Synthetic Colors in Some Locally Available Foods of Kashan City, Iran von Sharafati Chaleshtori, R., Golsorkhi, F.

Volltext

846PD - Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Up... von Abida, W., Campbell, D., Patnaik, A., Sautois, B., Shapiro, J., Vogelzang, N.J., Bryce, A.H., McDermott, R., Ricci, F., Rowe, J., Zhang, J., Simmons, A.D., Despain, D., Dowson, M., Golsorkhi, T., Chowdhury, S.

Volltext

Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated an... von Abida, W., Campbell, D., Patnaik, A., Sautois, B., Shapiro, J., Vogelzang, N.J., Bryce, A.H., McDermott, R., Ricci, F., Rowe, J., Zhang, J., Simmons, A.D., Despain, D., Dowson, M., Golsorkhi, T., Chowdhury, S.

Volltext

846PDPreliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updat... von Abida, W, Campbell, D, Patnaik, A, Sautois, B, Shapiro, J, Vogelzang, N J, Bryce, A H, McDermott, R, Ricci, F, Rowe, J, Zhang, J, Simmons, A D, Despain, D, Dowson, M, Golsorkhi, T, Chowdhury, S

Volltext

Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study von Yang, James Chih-Hsin, Reckamp, Karen L., Kim, Young-Chul, Novello, Silvia, Smit, Egbert F., Lee, Jong-Seok, Su, Wu-Chou, Akerley, Wallace L., Blakely, Collin M., Groen, Harry J.M., Bazhenova, Lyudmila, Carcereny Costa, Enric, Chiari, Rita, Hsia, Te-Chun, Golsorkhi, Tony, Despain, Darrin, Shih, Danny, Popat, Sanjay, Wakelee, Heather

Volltext

The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homol... von Chowdhury, S., Abida, W., Arranz Arija, J., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly Lobbedez, F., McDermott, R., Merseburger, A.S., Piulats Rodriguez, J.M., Sautois, B., Sridhar, S., Sternberg, C.N., Watkins, S., Simmons, A., Shetty, S., Golsorkhi, A., Ryan, C.J., Scher, H.

Volltext

TIGER-3: A phase 3 multinational open-label randomized study of rociletinib vs investigator-choice chemotherapy in patients (pts) with epidermal growth factor receptor mutant-posit... von Yang, James Chih-Hsin, Popat, Sanjay, Novello, Silvia, Groen, Harry J.M., Perol, Maurice, Felip, Enriqueta, Griesinger, Frank, Reckamp, Karen L., Lee, Jong-Seok, Smit, Egbert F., Blakely, Collin M., Akerley, Wallace L., Kim, Young-Chul, Bazhenova, Lyudmila, Califano, Raffaele, Hall, Richard Delmar, Georgiou, Panayiotis, Isaacson, Jeffrey D., Golsorkhi, Tony, Wakelee, Heather A.

Volltext

Efficacy and safety of rociletinib versus chemotherapy in patients with EGFR-mutated NSCLC: the results of TIGER-3, a phase 3 randomized study von Yang, JC-H, Reckamp, KL, Kim, Y-C, Novello, S, Smit, EF, Lee, J-S, Su, W-C, Akerley, WL, Blakely, CM, Groen, HJM, Bazhenova, L, Carcereny Costa, E, Chiari, R, Hsia, T-C, Golsorkhi, T, Despain, D, Shih, D, Popat, S, Wakelee, H

Volltext

P048 - The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homo... von Rodriguez-Vida, A., Arranz Arija, J.A., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly, F., Krieger, L., Mcdermott, R., Merseburger, A.S., Piulats, J.M., Sautois, B., Shapiro, J., Sridhar, S., Sternberg, C.N., Watkins, S., Simmons, A., Shetty, S., Golsorkhi, T., Abida, W., Ryan, C.J., Scher, H.I., Chowdhury, S.

Volltext

The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous... von Rodriguez-Vida, A., Arranz Arija, J.A., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly, F., Krieger, L., Mcdermott, R., Merseburger, A.S., Piulats, J.M., Sautois, B., Shapiro, J., Sridhar, S., Sternberg, C.N., Watkins, S., Simmons, A., Shetty, S., Golsorkhi, T., Abida, W., Ryan, C.J., Scher, H.I., Chowdhury, S.

Volltext

Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis von Owen, O E, Reichle, F A, Mozzoli, M A, Kreulen, T, Patel, M S, Elfenbein, I B, Golsorkhi, M, Chang, K H, Rao, N S, Sue, H S, Boden, G

Volltext

Prospective comparative clinical trial with distal splenorenal and mesocaval shunts von Reichle, Frederick A., Fahmy, Wasfy F., Golsorkhi, Mohammad

Volltext

Diagnosis and management of penetrating arterial and venous injuries in the extremities von Reichle, Frederick A., Golsorkhi, Muhammad

Volltext